|
Number of subjects (female/male)
|
106(62/44)
|
121 (66/55)
|
|
Age (years)
|
45.3 ± 12.7(19~ 72)
|
50.8 ± 16.7 (15~ 84)
|
|
FEV1§
|
4.1 ± 0.9 (2.7~ 5.3)**
|
2.1 ± 0.8 (1~ 4)**
|
|
FEV1§ (% predicted)
|
101.6 ± 11.9 (87.1~ 121.3)*
|
81.4 ± 22.2 (34~ 125)*
|
|
FVC∥ (% predicted)
|
95.2 ± 11.5 (77.9~ 112.9)
|
91.3 ± 17.8 (40~ 140)
|
|
FEV1/FVC (%)
|
91.6 ± 4.9 (84.8~ 97.9)**
|
71.9 ± 14.2 (35~ 98)**
|
|
Blood cells
|
Neutrophils
|
55.3 ± 9.7 (28.5~ 75.4)
|
59.5 ± 14.3 (27~ 92)
|
|
Lymphocytes
|
35.7 ± 9.3 (20~ 67.3)**
|
26.8 ± 11.0 (4~ 52)**
|
|
Monocytes
|
6.7 ± 3.2 (2.0~ 19.0)**
|
7.0 ± 2.7 (1~ 17)**
|
|
Eosinophils
|
2.0 ± 1.4 (0~ 6.0)**
|
5.7 ± 8.4 (0~ 55)**
|
|
Basophils
|
0.3 ± 0.3(0~ 1.3)*
|
0.5 ± 0.5 (0~ 4)*
|
|
BALF cells
|
Neutrophils
|
2.0 ± 1.6 (0~ 5.1)**
|
16.6 ± 26.7 (0~ 90)**
|
|
Lymphocytes
|
10.6 ± 8.4 (1.0~ 29.2)
|
16.9 ± 17.0 (0~ 69)
|
|
Macrophage
|
86.2 ± 10.4 (62.0~ 99.0)**
|
59.9 ± 27.8 (3~ 95)**
|
|
Eosinophils
|
0.2 ± 0.6 (0~ 1.9)
|
3.9 ± 8.5 (0~ 52)
|
|
Basophils
|
0 ± 0 (0~ 0)
|
0.04 ± 0.1(0~ 1)
|
|
Epithelial cells
|
0.8 ± 1.0 (0~ 2.5)
|
2.38 ± 9.6 (0~ 86)
|
| |
Total IgE
|
92.8 ± 143.4(2.2~ 694.2)**
|
376.4 ± 612.2 (2~ 3000)**
|
| |
Der p 1-specific IgE
|
0.8 ± 2.1(0~ 10.4)*
|
4.1 ± 15.3 (0~ 100)*
|
|
IgE
|
Der p 1-specific IgE (class)
|
0.4 ± 1.0(0~ 3)
|
0.62 ± 1.2 (0~ 5)
|
| |
Der f 1-specific IgE
|
1.5 ± 4.4(0~ 23.4)**
|
7.3 ± 19.5 (0~ 100)**
|
| |
Der f 1-specific IgE (class)
|
0.8 ± 1.2(0~ 4)
|
1.2 ± 1.5 (0~ 5)
|
